Med of the Week: Topiramate Teresa Mendoza, PharmD Jul 24, 2024 2 min read Updated: May 24, 2025 July is National Cleft and Craniofacial Awareness and Prevention Month
It is worth stating plainly that the phrase "no side effects" does not apply to any active skincare ingredient, including this one
After verifying the results of the previous, highly controlled studies, the researchers expanded their study population to make it more reflective of HFpEF cases in clinical practice, finding that overall, the drugs were associated with a greater than 40% reduction in heart failure hospitalization or all-cause mortality as compared with sitagliptin
The severity often peaks at weeks 2-3 when the medication reaches steady state in your bloodstream
Many studies 14 show GLP-1RAs effectively treat cardiovascular conditionslike atherosclerosis and hypertensionin non-diabetic and diabetic groups
actively seeking new molecular markers of ferroptosis and studying their value in disease diagnosis, progression monitoring, and treatment efficacy assessment